Circumcision In Africa: Guarding Against HPV, Cervical Cancer
1/07/2011
Over a quarter million women die each year in Uganda from cervical cancer. The primary cause is the human papillomavirus, or HPV. In 2010, vaccines were developed and introduction to the community has commenced. Recent randomised trials have also shown that when men are circumcised it provides protection against transmission of HPV to women...
Men's Openness To HPV Vaccine Could Bolster Impact Of New FDA Decision, Reduce Cancer Deaths
1/05/2011
Men are more willing to receive human papillomavirus (HPV) vaccine when they learn the vaccine can prevent cancer, according to a recent University of North Carolina at Chapel Hill study. The research reinforces hopes that a related decision by the U.S. Food and Drug Administration last month will lead to fewer cases and deaths from anal cancer...
Mothers Key To College-Age Women Receiving HPV Vaccine
1/04/2011
Even after young women reach adulthood, their mothers can play a key role in convincing them to receive the human papillomavirus (HPV) vaccine, new research suggests. A study found that college-aged women were more likely to say they had received the HPV vaccine if they had talked to their mother about it...
FDA Approves Gardasil For Anal Cancer Prevention
12/23/2010
Gardasil is now approved as a vaccine for preventing anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18, in males and females from 9 to 26 years old, said the The US Food and Drug Administration on Wednesday...
Revolutionizing Ovarian Cancer Treatment
12/23/2010
The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston (UH) scientist...
Cancer Sniffed Out By Electronic Nose
12/21/2010
Gyorgy Horvath from the University of Gothenburg, Sweden, and researchers from the University of Gavle and KTH Royal Institute of Technology have been able to confirm in tests that ovarian cancer tissue and healthy tissue smell different. The results were published recently in the journal Future Oncology...
Faster And More Reliable Ovarian Cancer Diagnosis
12/16/2010
It is crucial to differentiate between benign and malignant ovarian cysts and tumours in a fast and reliable manner. This improves the surgical management and prognosis of the patient...
EGEN, Inc. Announces That Phase II Clinical Trial For Advanced Ovarian Cancer Is Open For Enrollment
12/15/2010
EGEN, Inc. announced that the first Phase II clinical trial utilizing EGEN-001 for the treatment of recurrent ovarian cancer is now open for enrollment. The trial is sponsored by the Gynecologic Oncology Group (GOG) under an agreement between the GOG and EGEN, Inc., and is being conducted by a network of researchers led by the GOG at member institutions...
Scientists Identify How Virus Triggers Cervical And Mouth Cancer
12/15/2010
University of Manchester scientists have discovered for the first time an important new way in which the human papilloma virus (HPV) triggers cancer in what could lead to new treatments for cervical and mouth cancer...
Program Reduces Cervical Cancer Deaths Among HIV-infected Women In Zambia
12/15/2010
A new study undertaken in Zambia shows that, using setting-appropriate human resources and technology, morbidity and mortality from cervical cancer among HIV-infected women can be reduced...